These results support the inference that serum AGP may reflect the accumulation of inflammation, which ultimately accelerates the progression to ESKD in patients with AAV, based on previous studies showing that serum AGP reflected the inflammatory burden of chronic kidney diseases [19,20]. Here, ATP5MK is linked to chronic kidney disease.